Skip to content

Clinical trials

Phase 3 Liver Cirrhosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Phase 3 Country / region: United Kingdom Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20111
20151
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
Boehringer Ingelheim1
King's College London1
Madrigal Pharmaceuticals, Inc.1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Newcastle-upon-Tyne Hospitals NHS Trust1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis8
Fibrosis3
Ascites2
Non-alcoholic Fatty Liver Disease2
Esophageal and Gastric Varices1
Fatty Liver, Alcoholic1
Hepatic Encephalopathy1
Hepatic Insufficiency1
Hypertension, Portal1
Hypotension1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.